U.S. Physical Therapy Inc... (USPH)
NYSE: USPH
· Real-Time Price · USD
75.54
1.26 (1.70%)
At close: Jun 23, 2025, 3:59 PM
75.64
0.13%
After-hours: Jun 23, 2025, 04:04 PM EDT
U.S. Physical Therapy Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Net Patient Revenues Revenue | 560.55M | 514.56M | 464.59M | 438.33M | 373.34M | 433.35M | 417.7M |
| Net Patient Revenues Revenue Growth | +8.94% | +10.75% | +5.99% | +17.41% | -13.85% | +3.74% | n/a |
| Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues Revenue | 110.79M | 90.25M | n/a | n/a | n/a | n/a | n/a |
| Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues Revenue Growth | +22.77% | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | 17.99M | 16.11M | 11.45M | 15.71M | 11.36M | 9.61M | 12.14M | 13.86M | 11.93M | 11.89M | 10.74M | 11.56M | 10.72M | 12.87M | 12.07M | 10.87M | 10.92M | 10.42M | 9.02M | 11.68M | 11.67M | 10.56M | 11.53M | 11.29M | 10.41M | 10.64M | 10.13M | 10.16M | 10.18M | 8.3M | 8.86M | 8.55M | 7.84M | 7.61M | 8.03M | 9M | 8.89M | 6.92M | 7.59M | 7.66M |
| Selling, General, and Administrative Revenue Growth | -100.00% | +11.69% | +40.64% | -27.11% | +38.31% | +18.26% | -20.91% | -12.37% | +16.22% | +0.30% | +10.69% | -7.05% | +7.82% | -16.70% | +6.57% | +11.04% | -0.38% | +4.74% | +15.52% | -22.74% | +0.03% | +10.58% | -8.42% | +2.07% | +8.43% | -2.14% | +5.08% | -0.34% | -0.19% | +22.62% | -6.23% | +3.62% | +9.03% | +3.01% | -5.18% | -10.86% | +1.24% | +28.47% | -8.82% | -0.84% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |